Clinical Trial Update: Phase III Trial to Assess the Safety and Efficacy of TK-254RX in Patients With Contusions [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating TK-254RX for contusions has completed; no results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contusion

Drugs mentioned

• TK-254RX (TK-254RX)

Snippet

Sponsor: Teikoku Seiyaku Co., Ltd. | Conditions: Contusions | Phase 3 | Status: COMPLETED